Keyphrases
Anti-PM-Scl Antibody
12%
Anti-Ro Antibodies
12%
Anti-Ro52 Antibody
37%
Anti-Scl70
12%
Anti-SSA
100%
Anti-SSB
12%
Anticentromere
12%
Antinuclear Antibodies
12%
Autoantibodies
100%
Clinical Characteristics
12%
Clinical Manifestations
37%
Consecutive Patients
12%
Cross-sectional Observational Study
100%
Demographic Characteristics
12%
Diagnostic Utility
12%
Idiopathic Inflammatory Myopathies
12%
Immunoblot
12%
Indirect Immunofluorescence
12%
Inflammatory Myositis
12%
Limited Form
12%
Patient Characteristics
12%
Ro52
100%
Scleroderma
100%
Sine
12%
Small nuclear Ribonucleoprotein (snRNP)
12%
Spanish Cohort
12%
Statistical Analysis
12%
Systemic Sclerosis
50%
Immunology and Microbiology
Antinuclear Antibody
25%
Autoantibodies
100%
Centromere
25%
Immunofluorescence
25%
Immunology
75%
Myositis
50%
Prevalence
25%
Ro Antibody
25%
Scleroderma
100%
Systemic Scleroderma
100%
Western Blot
25%
Biochemistry, Genetics and Molecular Biology
Autoantibodies
100%
Centromere
50%
Cross Sectional Study
100%
Immunoblotting
50%
Immunofluorescence
50%
Observational Study
50%
Prevalence
50%